Category: Patent Litigation
-
UPC Munich LD revokes Promosome’s mRNA patent, dismisses infringement claims against BioNTech, Pfizer over Comirnaty
The UPC’s Munich LD revoked Promosome’s mRNA patent as invalid over prior art and found no infringement by BioNTech and Pfizer’s Comirnaty vaccine, ending the dispute.
-
Ericsson wins first-ever African SEP injunction in Morocco: Casablanca Trade Court enjoins Transsion over four 4G/5G patents
A Moroccon media outlet reports that Ericsson has been granted injunctive relief against Transsion in the North African country. This is the first African SEP injunction in history.
-
American Express prevails as plaintiff’s second amended complaint dismissed with prejudice: “No basis to reach a different result”
Loyal-T Systems LLC did not sufficiently improve or change the arguments it put forth, leaving a Federal Circuit appeal its only remaining option.
-
Nixu FL brings UPC action against AWS over cloud networking technology
Nixu FL IP Protection has filed a patent infringement action against multiple Amazon Web Services entities before the UPC’s Milan Local Division, asserting a cloud networking patent and seeking pan-UPC remedies.
-
Panasonic and OPPO, Nokia and Huawei trade SEPs in newly recorded U.S. transfers
Both assignments are emblematic of how smaller-scale asset transfers involving SEPs take place in the context of broader deals between operating companies.
-
Supercomputer firm ParTec sues Google and AMD/Bull at UPC Mannheim: third UPC venue chosen in this campaign
Apparently energized by a recent settlement with Microsoft, the German supercomputer firm led by a former patent litigator and monetizer is on fire.
-
Infineon continues winning streak against Innoscience in Germany
In the gallium nitride patent wars, Infineon has gained significant ground against Innoscience in the Munich I Regional Court, which has issued its third ruling in favor of the patentee in less than a month.
-
Delhi High Court orders Transsion to pay pro tem security to InterDigital
“Granting pro tem security balances the asymmetric advantage that an implementer has over an SEP holder,” the court emphasized in its judgment.
-
UPC CoA rejects Guardant’s provisional measures appeal against Sophia Genetics on urgency grounds; reverses added matter finding
The UPC’s CoA has dismissed Guardant Health’s provisional measures appeal over a cancer-detection patent against Sophia Genetics, finding an unexplained three-month gap fatal to urgency, though it reversed the added matter ruling below.